TGFBR2 and non-small cell lung carcinoma: Fang and colleagues have reported that miR-30c-2-3p targeted TGFBR2 and USP15 in non-small cell lung cancer (NSCLC) cells, leading to the inactivation of TGF-β signaling (Fang et al. 2019).